Mike Jeon

1.1k total citations · 1 hit paper
15 papers, 919 citations indexed

About

Mike Jeon is a scholar working on Biomaterials, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Mike Jeon has authored 15 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Biomaterials, 9 papers in Biomedical Engineering and 6 papers in Molecular Biology. Recurrent topics in Mike Jeon's work include Nanoparticle-Based Drug Delivery (12 papers), RNA Interference and Gene Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Mike Jeon is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), RNA Interference and Gene Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Mike Jeon collaborates with scholars based in United States, China and Taiwan. Mike Jeon's co-authors include Miqin Zhang, Zachary R. Stephen, Forrest M. Kievit, Qingxin Mu, Guanyou Lin, Richard A. Revia, Kui Wang, Richard G. Ellenbogen, Kui Wang and John R. Silber and has published in prestigious journals such as Advanced Materials, ACS Nano and Cancer Research.

In The Last Decade

Mike Jeon

15 papers receiving 905 citations

Hit Papers

Iron Oxide Nanoparticles as T1 Contrast Agents for Magnet... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Jeon United States 13 502 478 275 261 92 15 919
Zhongling Wang China 17 681 1.4× 500 1.0× 284 1.0× 334 1.3× 102 1.1× 41 1.1k
Jiefu Jin United States 14 511 1.0× 230 0.5× 244 0.9× 344 1.3× 72 0.8× 21 880
Аlyssa M. Master United States 12 713 1.4× 368 0.8× 243 0.9× 342 1.3× 37 0.4× 15 1.1k
Y. Andrew Wang United States 10 553 1.1× 508 1.1× 387 1.4× 208 0.8× 137 1.5× 18 1.0k
Hyeyoun Chang South Korea 13 543 1.1× 366 0.8× 310 1.1× 200 0.8× 46 0.5× 17 987
Donghoon Lee United States 8 513 1.0× 530 1.1× 313 1.1× 233 0.9× 64 0.7× 9 962
Cinzia Stigliano United States 15 357 0.7× 319 0.7× 290 1.1× 136 0.5× 42 0.5× 20 783
Julie Czupryna United States 9 377 0.8× 340 0.7× 216 0.8× 180 0.7× 88 1.0× 10 741
Canan Schumann United States 15 648 1.3× 447 0.9× 257 0.9× 268 1.0× 24 0.3× 17 984

Countries citing papers authored by Mike Jeon

Since Specialization
Citations

This map shows the geographic impact of Mike Jeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Jeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Jeon more than expected).

Fields of papers citing papers by Mike Jeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Jeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Jeon. The network helps show where Mike Jeon may publish in the future.

Co-authorship network of co-authors of Mike Jeon

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Jeon. A scholar is included among the top collaborators of Mike Jeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Jeon. Mike Jeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mu, Qingxin, Guanyou Lin, Mike Jeon, et al.. (2021). Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer. Materials Today. 50. 149–169. 58 indexed citations
2.
Jeon, Mike, Guanyou Lin, Zachary R. Stephen, et al.. (2020). Cocaine analogue conjugated magnetic nanoparticles for labeling and imaging dopaminergic neurons. Biomaterials Science. 8(15). 4166–4175. 3 indexed citations
3.
Jeon, Mike, et al.. (2020). Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives. Advanced Materials. 33(23). e1906539–e1906539. 348 indexed citations breakdown →
4.
Lin, Guanyou, Qingxin Mu, Richard A. Revia, et al.. (2020). A highly selective iron oxide-based imaging nanoparticle for long-term monitoring of drug-induced tumor cell apoptosis. Biomaterials Science. 9(2). 471–481. 5 indexed citations
5.
Stephen, Zachary R., Peter A. Chiarelli, Richard A. Revia, et al.. (2019). Time-Resolved MRI Assessment of Convection-Enhanced Delivery by Targeted and Nontargeted Nanoparticles in a Human Glioblastoma Mouse Model. Cancer Research. 79(18). 4776–4786. 32 indexed citations
6.
Jeon, Mike, et al.. (2019). Paclitaxel‐Loaded Iron Oxide Nanoparticles for Targeted Breast Cancer Therapy. Advanced Therapeutics. 2(12). 33 indexed citations
7.
Stephen, Zachary R., et al.. (2019). Catalase‐Functionalized Iron Oxide Nanoparticles Reverse Hypoxia‐Induced Chemotherapeutic Resistance. Advanced Healthcare Materials. 8(20). e1900826–e1900826. 29 indexed citations
8.
Chiarelli, Peter A., Richard A. Revia, Zachary R. Stephen, et al.. (2017). Nanoparticle Biokinetics in Mice and Nonhuman Primates. ACS Nano. 11(9). 9514–9524. 34 indexed citations
9.
Stephen, Zachary R., et al.. (2016). Approach to Rapid Synthesis and Functionalization of Iron Oxide Nanoparticles for High Gene Transfection. ACS Applied Materials & Interfaces. 8(10). 6320–6328. 55 indexed citations
10.
Wang, Hui, Kui Wang, Richard A. Revia, et al.. (2016). Preloading of Hydrophobic Anticancer Drug into Multifunctional Nanocarrier for Multimodal Imaging, NIR‐Responsive Drug Release, and Synergistic Therapy. Small. 12(46). 6388–6397. 46 indexed citations
11.
Stephen, Zachary R., et al.. (2016). pH-Sensitive O6-Benzylguanosine Polymer Modified Magnetic Nanoparticles for Treatment of Glioblastomas. Bioconjugate Chemistry. 28(1). 194–202. 14 indexed citations
12.
Mu, Qingxin, Forrest M. Kievit, Rajeev J. Kant, et al.. (2015). Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells. Nanoscale. 7(43). 18010–18014. 78 indexed citations
13.
Wang, Kui, Forrest M. Kievit, Jonathan G. Sham, et al.. (2015). Iron-Oxide-Based Nanovector for Tumor Targeted siRNA Delivery in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model. Small. 12(4). 477–487. 63 indexed citations
14.
Mu, Qingxin, et al.. (2015). Stable and Efficient Paclitaxel Nanoparticles for Targeted Glioblastoma Therapy. Advanced Healthcare Materials. 4(8). 1236–1245. 46 indexed citations
15.
Wang, Kui, Forrest M. Kievit, Mike Jeon, et al.. (2015). Nanoparticle‐Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma. Advanced Healthcare Materials. 4(17). 2719–2726. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026